Immunotherapies could target aggressive pancreatic cancer, research indicates
The Pharma Data
SEPTEMBER 3, 2020
Our new study offers an important basis from which to start developing new treatment strategies for a rare form of cancer, which starts in the hormone-producing cells of the pancreas,” noted Dr Anguraj Sadanandam, team leader in Systems and Precision Cancer Medicine at The ICR, London. “We
52 
Let's personalize your content